Benzinga | Apr 29, 2021 06:29AM EDT

SVB Leerink Maintains Outperform on Hologic, Lowers Price Target to $85

SVB Leerink analyst Richard Newitter maintains Hologic (NASDAQ:HOLX) with a Outperform and lowers the price target from $94 to $85.